A HUMAN (PHASE 0) SINGLE MICRODOSE METABOLIC PROFILING STUDY OF [14C]-GMC-252 IN HEALTHY MALE SUBJECTS

A HUMAN (PHASE 0) SINGLE MICRODOSE METABOLIC PROFILING STUDY OF [14C]-GMC-252 IN HEALTHY MALE SUBJECTS - [14C]-GMC-252 microdose study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34475

Enrollment

Registered

2010-09-03

Start date

2010-10-06

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes Diabetes Mellitus Type 2

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: healthy male volunteers - age between 18 and 55 years - BMI is between 18 and 35 kg/m2 - non smoker or light or moderate smoker, i.e. * 10 cigarettes a day - at screening the state of health must satisfy the entry requirements

Exclusion criteria

Exclusion criteria: - Participation in a clinical trial within the previous 60 days prior to drug administration. - Participation in a clinical trial involving the administration of a [14C]-labelled compound within the previous 6 months prior to drug administration. - Evidence of clinically relevant pathology

Design outcomes

Primary

Measure	Time frame
Pharmacokinetics Metabolic profiling Safety	—

Countries

Netherlands

Outcome results